An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) - Wikidata - wikimedia - TriplyDB

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

http://www.wikidata.org/entity/Q29615693

about

Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma The Role of PPARs in Cancer Diverse convergent evidence in the genetic analysis of complex disease: coordinating omic, informatic, and experimental evidence to better identify and validate risk factors Mammalian ste20-like kinase and SAV1 promote 3T3-L1 adipocyte differentiation by activation of PPARγ Cytosolic aspartate aminotransferase, a new partner in adipocyte glyceroneogenesis and an atypical target of thiazolidinedione The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity Inflammation, stress, and diabetes PPARdelta regulates glucose metabolism and insulin sensitivity PPAR delta: a dagger in the heart of the metabolic syndrome.Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gamma The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1 Abscisic acid regulates inflammation via ligand-binding domain-independent activation of peroxisome proliferator-activated receptor gamma PPARs and the cardiovascular system Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease The in vitro real-time oscillation monitoring system identifies potential entrainment factors for circadian clocks.Peroxisome Proliferator-Activated Receptors in Female Reproduction and Fertility Insulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycle Protective roles of free avian respiratory macrophages in captive birds Hydroxycinnamic acid derivatives: a potential class of natural compounds for the management of lipid metabolism and obesity Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders Zebrafish as a Model to Study the Role of Peroxisome Proliferating-Activated Receptors in Adipogenesis and Obesity Unlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and Obesity Orphan nuclear receptors and the regulation of nutrient metabolism: understanding obesity Adipogenesis Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention Nuclear receptors in bone physiology and diseases

P2860

Q21090765-16C346AD-050F-4796-9E51-B5E50C53E53F Q21342955-E1D83200-A2AD-4E57-A5D8-CA71A88D5EBE Q24288911-31E6C25E-19BD-4A20-8F31-4F1C9B2862DB Q24304151-0F4F862A-828C-4D70-B2A3-743A54177BB8 Q24307812-A471AEED-129A-4133-B620-61DDC141C88E Q24310512-83DF4355-1AE0-4AE9-8DE0-14D819084FDA Q24314755-EFA7616C-CA1C-4B3E-A503-E905134A8545 Q24316367-FDC001D1-0A4F-4F5F-A7DD-E15786719809 Q24322799-1C768FB1-2BDB-423D-AA78-B0D7DC221469 Q24523336-7C689C01-3239-478E-A485-0C45006EFCD2 Q24541495-866FB5F9-126E-4937-B79A-EA205E84AF5E Q24541527-7963C71B-89E9-4932-BB78-2E6AEF17ABEC Q24541529-42CD45D9-AB26-4BAE-B3DC-C013EB129401 Q24553023-9D886411-3AB9-496A-AA7C-D9F0A60F36CA Q24553125-F2CB8F45-BF9B-470C-A9F3-46B5D5D9D711 Q24555727-7E23D07B-757D-453A-BB23-489F3ABE83AE Q24561401-A42424AF-6D37-44E3-95F8-6E7069723942 Q24567657-9339BA97-4FD8-4100-BF31-2FFAB8CD140E Q24612698-A23CD0CF-4FDC-4E59-BED6-1F37EEC80A9D Q24633440-8578D90E-F330-489F-868A-AA4904168E8F Q24634256-92C0A0DA-5F1D-4251-B5A8-65EE4AB1E088 Q24642728-9DCEAE75-EF6C-41B0-993A-9EFADD9F9758 Q24642826-84811978-3DA1-43B7-B2D9-9FD844D60899 Q24645513-D8441D39-FED5-4872-81F7-552019ADF70A Q24652687-D9489797-4CF2-4AD8-9D7F-B907BCFA19DA Q24655111-DAFEBC90-5B5D-46F9-8475-28C67992B97B Q24791420-FCA67F9E-9DF4-46FA-BDE0-C60A24D8613C Q24803926-3CE5FFEA-F0DD-444A-9BA7-76122C63FD86 Q25256792-35009A97-9023-4C49-8152-D1B57B49C765 Q26738962-7F36A288-E32C-46E2-8DC4-FD0BFE61A1CD Q26745509-1BD25C56-1FCE-41F6-8160-4B4CF71F3860 Q26745831-04CA04CF-E6FD-4834-BDA5-D13255AE61EE Q26749072-ABD89302-A2C0-4030-87AD-150A38EC8339 Q26752618-D2F3B0B8-FD38-4307-AACB-1812D0CF0C24 Q26772316-15A18054-2606-4F5D-8830-252B77CB5B2B Q26774736-85B78E42-4F61-46F4-98BC-1F87B6606F60 Q26823819-C45B1EF2-602F-40BB-81B5-4C67E70392D2 Q26828614-6A5EFC40-667C-435A-8F78-74C2705F9B07 Q26851905-AF2F9C67-CDEB-43B9-881F-D79BD41F5384 Q26853017-C91FB951-8BFD-4A8F-A878-1AD313D4CD74

P2860

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

http://www.wikidata.org/entity/Q29615693

description

1995 nî lūn-bûn

@nan

1995 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

An antidiabetic thiazolidinedi ...... ed receptor gamma (PPAR gamma)

@ast

An antidiabetic thiazolidinedi ...... ed receptor gamma (PPAR gamma)

@en

type

label

An antidiabetic thiazolidinedi ...... ed receptor gamma (PPAR gamma)

@ast

An antidiabetic thiazolidinedi ...... ed receptor gamma (PPAR gamma)

@en

prefLabel

An antidiabetic thiazolidinedi ...... ed receptor gamma (PPAR gamma)

@ast

An antidiabetic thiazolidinedi ...... ed receptor gamma (PPAR gamma)

@en

P1433

Q29615693-DE04332E-A52B-463F-A5F0-26A2F2DD7FA8

P1476

Q29615693-FC3B2001-2448-47E6-A0D5-5E5A73594630

P2093

Q29615693-437884F7-1A01-4EE5-97B8-80D7133DC2EE

Q29615693-557325A4-7B01-461B-B98B-43D4651141AF

Q29615693-5C40CCB5-C0B5-42E4-B18D-59492CE47508

Q29615693-94CC557C-FF71-46C3-A4A7-7AB20028F71A

Q29615693-B4787230-4207-435D-A380-133254547EE6

Q29615693-F70F9759-ABC4-427D-B3CA-0E84ADBB2518

P304

Q29615693-08CDB911-8854-4351-BAFC-3DEB118E5A34

P31

Q29615693-B1C1A923-6E3E-4DF0-90F2-E7A794203010

P3181

Q29615693-154807CF-DF4E-4117-8D4B-58F611223A96

P356

Q29615693-4D0F3745-7790-4E9F-8EFE-07447094AACA

P407

Q29615693-73F6A8B9-D4E6-42D9-85C7-ECB17EBCED82

P433

Q29615693-1EA1C046-43F9-4FBC-98EA-3E2BE2CA9F5C

P478

Q29615693-314FB302-D8E1-44CF-A8E9-6965333E0CAE

P577

Q29615693-37B18E84-6EAD-48D2-B100-7448774A3CB5

P5875

Q29615693-683424EE-EAD3-404B-AF4D-9EAC26EEDBD7

P698

Q29615693-13C568E0-7A2D-4816-8DA1-BEF9E7574EED

P3181

P356

JBC.270.22.12953

P1433

Journal of Biological Chemistry

P1476

An antidiabetic thiazolidinedi ...... ed receptor gamma (PPAR gamma)

@en

P2093

Kliewer SA

http://www.w3.org/2001/XMLSchema#string

Lehmann JM

http://www.w3.org/2001/XMLSchema#string

Moore LB

http://www.w3.org/2001/XMLSchema#string

Smith-Oliver TA

http://www.w3.org/2001/XMLSchema#string

Wilkison WO

http://www.w3.org/2001/XMLSchema#string

Willson TM

http://www.w3.org/2001/XMLSchema#string

P304

12953-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

67977

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.270.22.12953

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

270

http://www.w3.org/2001/XMLSchema#string

P577

1995-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15430073

http://www.w3.org/2001/XMLSchema#string

P698

7768881

http://www.w3.org/2001/XMLSchema#string